Literature DB >> 15855744

Can screening for retinopathy of prematurity be reduced?

J U M Termote1, A R T Donders, N E Schalij-Delfos, C H Lenselink, C S Derkzen van Angeren, S C J L Lissone, B P Cats.   

Abstract

BACKGROUND: As screening for retinopathy of prematurity (ROP) is costly, time-consuming for the ophthalmologist and discomforting for the neonate, the minimum number of infants should be screened for ROP, without missing infants with severe ROP, at risk for threshold ROP.
OBJECTIVES: To develop a diagnostic screening guideline for ROP that would safely reduce the number of ROP screening funduscopies in our department.
METHODS: Data of 275 infants admitted between 1996 and 2000 and screened for ROP according to our Dutch National guideline were studied. Significant risk factors for ROP were calculated, using logistic regression analysis and used to develop a guideline. The discriminative power of the guideline was evaluated using the area under the curve for the receiver operating characteristic curve.
RESULTS: Significant risk factors for ROP were: gestational age, birth weight and number of erythrocyte transfusions within the first 4 weeks of life. The combination of these 3 factors resulted in the highest area under the curve: 0.793. Using these 3 factors, a diagnostic screening guideline for ROP was developed: if birth weight + 2 x (gestational age - 20) - 6 x erythrocyte transfusion value within the first 4 weeks of life >or=34, no screening for ROP is necessary. Using this guideline, 22.2% of the infants of the study group could have been excluded from screening; 3.8% of the infants with ROP stages 1-2 would have been missed.
CONCLUSION: In our department, ROP screening can be safely reduced using our diagnostic screening guideline. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2005        PMID: 15855744     DOI: 10.1159/000085295

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  4 in total

1.  Risk Score for Predicting Treatment-Requiring Retinopathy of Prematurity (ROP) in the Telemedicine Approaches to Evaluating Acute-Phase ROP Study.

Authors:  Gui-Shuang Ying; Deborah VanderVeen; Ebenezer Daniel; Graham E Quinn; Agnieshka Baumritter
Journal:  Ophthalmology       Date:  2016-08-02       Impact factor: 12.079

Review 2.  Retinopathy of prematurity: a review of risk factors and their clinical significance.

Authors:  Sang Jin Kim; Alexander D Port; Ryan Swan; J Peter Campbell; R V Paul Chan; Michael F Chiang
Journal:  Surv Ophthalmol       Date:  2018-04-19       Impact factor: 6.048

3.  Factors associated with retinopathy of prematurity ophthalmology workload.

Authors:  Jack Jacob; Zinnia Matrix; Debra Skopec; Benjamin Ticho; Robert W Arnold
Journal:  J Perinatol       Date:  2018-08-31       Impact factor: 2.521

4.  Retinal Oximetry with Scanning Laser Ophthalmoscope in Infants.

Authors:  Wouter B Vehmeijer; Vigdis Magnusdottir; Thorunn S Eliasdottir; Sveinn Hakon Hardarson; Nicoline E Schalij-Delfos; Einar Stefánsson
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.